The health system’s researchers will pilot the technology for the Children’s Rare Disease Cohorts Initiative, according to a Dec. 6 press release from PacBio. The aim is to use the technology to investigate genetic and epigenetic variants associated with rare pediatric diseases.
The technology will examine samples from individuals enrolled in multiple rare disease cohorts.
“HiFi sequencing holds the promise to investigate parts of the genome inaccessible via other technologies,” said Piotr Sliz, PhD, vice president and chief research information officer at Boston Children’s Hospital. “We hope that HiFi sequencing will enable us to explore variation in parts of the genome that were not previously detected, potentially enabling us to expand our understanding of causative variation in these patients.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.